Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2024. Review the filing volume, DOL certification record, and offered-wage context below.
Cambridge, MA NAICS: 541714
U.S. Department of Labor's OFLC discloses 11 Labor Condition Application filings naming ReNAgade Therapeutics Management, Inc. from FY2023 through FY2024, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 3 H-1B petitions naming ReNAgade Therapeutics Management, Inc. through FY2023, and approved nearly every one of them: 100% approved (3 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
ReNAgade Therapeutics Management, Inc. is listed in 11 DOL LCA filings, more filings than 86% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $126,631. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2024). Based in Cambridge, MA.
ReNAgade Therapeutics Management, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
11 17820th of 122824 higher than 105,004 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2024
Derived from this employer's disclosed LCAs on file (FY2023–FY2024), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $85,000–$180,000 .
DOL LCA release change
On 11 LCAs with comparable offered vs prevailing wages, ReNAgade Therapeutics Management, Inc. averages about 14.6% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (45.5% of LCA filings).
Only 11 LCAs on file for ReNAgade Therapeutics Management, Inc., and 90.9% land in CAMBRIDGE CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$126,631
Above portal avg
Total Workers
11
Small worker count
Compensation range for H-1B positions at ReNAgade Therapeutics Management, Inc.
Wage vs. DOL Minimum
+14.6%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
45.5% of LCA filings
Full-Time Positions
100%
Primary Worksite County
CAMBRIDGE CITY, MA
90.9% of LCA filings
Most frequently listed job titles at ReNAgade Therapeutics Management, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Scientist | 2 | $155,000 |
| Senior Research Associate | 2 | $90,884 |
| Principal Research Associate | 2 | $109,116 |
| Scientist II Delivery Chemistry | 1 | $140,000 |
| Scientist II | 1 | $137,887 |
| Scientist I | 1 | $113,050 |
| Principal Scientist, NGS | 1 | $180,000 |
| Associate Scientist | 1 | $112,000 |
Cross-state DOL neighbors for ReNAgade Therapeutics Management, Inc. - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (11 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($126,631 here).
ReNAgade Therapeutics Management, Inc. is listed in 11 DOL Labor Condition Application filings covering 11 listed worker positions from FY2023 to FY2024. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, ReNAgade Therapeutics Management, Inc. ranks #16713 by total LCA filing count (11 filings). 105,004 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
ReNAgade Therapeutics Management, Inc. has a 100% DOL certification rate, with 11 out of 11 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in ReNAgade Therapeutics Management, Inc.'s LCAs is $126,631. Listed wages range from $85,000 to $180,000 and are not verified actual compensation.
The top job titles in ReNAgade Therapeutics Management, Inc.'s LCA filing records include Senior Scientist, Senior Research Associate, Principal Research Associate. The most common listed title is Senior Scientist with 2 LCA filings at an average listed offered wage of $155,000. This does not establish actual job openings, hiring, or approved petitions.
ReNAgade Therapeutics Management, Inc. is headquartered in Cambridge, MA.
No, ReNAgade Therapeutics Management, Inc. is not classified as H-1B dependent.
ReNAgade Therapeutics Management, Inc. is listed in 2 LCA filings in FY2023 and 9 in FY2024. The average listed offered wage changed from $132,500 to $125,326. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs ReNAgade Therapeutics Management, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs ReNAgade Therapeutics Management, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs ReNAgade Therapeutics Management, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs ReNAgade Therapeutics Management, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from ReNAgade Therapeutics Management, Inc.'s MICRO-BOOK.
Open the MA state board after the ABS peers. ReNAgade Therapeutics Management, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
ReNAgade Therapeutics Management, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for ReNAgade Therapeutics Management, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.